Amgen (AMGN) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification) and isn't treated as a signal here.
Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.- Next earnings expected around Feb 2, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Sale Rachna Khosla, Svp, Business Development sold 2,000 shares at $412.57 ($825K).
- Trade date
- Aug 11, 2026
- Disclosed to the SEC
- Aug 13, 2026
- Type
- Sale (code S)
Read the original SEC filing ↗All AMGN insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
AMGN insider transactions (Form 4)
Open-market purchases and sales. 115 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 13SEC | Rachna KhoslaSvp, Business Development | Sell | 2,0006,404 held (−24%) | $412.57 | $825K | +6.4% | — |
| Aug 13SEC | Rachna KhoslaSvp, Business Development | Sell | 1,2526,404 held (−16%) | $416.43 | $521K | +5.4% | — |
| Aug 7SEC | Derek MillerSvp, Human Resources | Sell | 2,06912,462 held (−14%) | $402.54 | $833K | +9.0% | — |
| Aug 7SEC | Nancy A. GrygielSvp & Cco | Sell | 1,9707,340 held (−21%) | $402.16 | $792K | +9.1% | — |
| Aug 7SEC | Derek MillerSvp, Human Resources | Sell | 1,82112,462 held (−13%) | $402.54 | $733K | +9.0% | — |
| Aug 7SEC | Nancy A. GrygielSvp & Cco | Sell | 1,0007,340 held (−12%) | $402.16 | $402K | +9.1% | — |
| May 5SEC | Nancy A. GrygielSvp & Cco | Sell | 1,2377,009 held (−15%) | $323.73 | $400K | +35.6% | — |
| Mar 2SEC | Esteban SantosEvp, Operations | Sell | 30,50176,618 held (−28%) | $379.12 | $11.6M | +15.8% | — |
| Mar 2SEC | Esteban SantosEvp, Operations | Sell | 24,29176,618 held (−24%) | $379.12 | $9.2M | +15.8% | — |
| Feb 20SEC | Matthew C. BuschVp, Finance & Cao | Sell | 1,0003,423 held (−23%) | $375.79 | $376K | +16.8% | — |
| Nov 21SEC | Nancy A. GrygielSvp & Cco | Sell | 1,6397,225 held (−18%) | $337.26 | $553K | +30.1% | — |
| Nov 21SEC | Nancy A. GrygielSvp & Cco | Sell | 1,5007,225 held (−17%) | $337.26 | $506K | +30.1% | — |
| Nov 13SEC | Murdo GordonEvp, Global Commercial Ops | Sell | 6,87941,923 held (−14%) | $336.83 | $2.3M | +30.3% | — |
| Nov 13SEC | Rachna KhoslaSvp, Business Development | Sell | 8907,082 held (−11%) | $336.24 | $299K | +30.5% | — |
Similar past setups: not applicable. AMGN has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with AMGN in the Research Lab
AMGN has no open-market insider buys in the last 12 months. Try the tools with any setup.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
Amgen insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 5 sold $26.7M of AMGN stock on the open market; P/E 28.5 vs. a sector median of 25.0.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
AMGN insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $4.1M | 6 |
| Q2 2026 | — | 0 | $400K | 1 |
| Q1 2026 | — | 0 | $21.1M | 3 |
| Q4 2025 | — | 0 | $3.7M | 4 |
Valuation, profit and volume
Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 0 Amgen insiders reported open-market purchases totaling $0, while 5 insiders reported sales totaling $26.7M. 0 of 14 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
AMGN earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Nov 3, 2026 | +7.6% | None | +2.8%S&P +2.0% | pending |
| Aug 4, 2026 | +3.4% | None | +7.6%S&P +1.6% | +7.8% |
| Apr 30, 2026 | -3.7% | None | -2.4%S&P +1.3% | +2.9% |
| Feb 3, 2026 | +4.3% | None | +6.2%S&P -1.3% | +1.6% |
| Nov 4, 2025 | -0.8% | None | +8.0%S&P -0.8% | +3.9% |
| Aug 5, 2025 | +2.4% | None | -5.7%S&P +0.3% | +0.4% |
| May 1, 2025 | -1.5% | None | -3.3%S&P +2.2% | +3.4% |
| Feb 4, 2025 | +6.2% | None | +6.6%S&P +1.1% | +6.4% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
AMGN short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded AMGN
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| Sheldon WhitehouseSenate | Sold $15,001 - $50,000 | Oct 15, 2026 | Nov 2, 2026 | +1.1% |
| Sheldon WhitehouseSenate | Sold $1,001 - $15,000 | Aug 12, 2026 | Sep 2, 2026 | +6.1% |
| Thomas H TubervilleSenate | Sold $15,001 - $50,000 | Apr 15, 2025 | Aug 5, 2026 | +55.4% |
| Alan ArmstrongSenate | Sold $15,001 - $50,000 | Mar 27, 2026 | Jul 21, 2026 | +27.5% |
| Sheldon WhitehouseSenate | Sold $1,001 - $15,000 | Sep 4, 2025 | Oct 3, 2025 | +61.0% |
Insiders at Amgen
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Esteban SantosEvp, Operations | — | $20.8M | May 11, 2026 | — | — |
| Nancy A. GrygielSvp & Cco | — | $2.7M | Aug 7, 2026 | — | — |
| Murdo GordonEvp, Global Commercial Ops | — | $2.3M | May 11, 2026 | — | — |
| Rachna KhoslaSvp, Business Development | — | $1.6M | Aug 13, 2026 | — | — |
| Derek MillerSvp, Human Resources | — | $1.6M | Aug 7, 2026 | — | — |
| Matthew C. BuschVp, Finance & Cao | — | $376K | Aug 12, 2026 | — | — |
| Michael V. DrakeDirector | — | — | Nov 9, 2026 | — | — |
| David W. GibbsDirector | — | — | Nov 9, 2026 | — | — |
| Charles M. HolleyDirector | — | — | Nov 9, 2026 | — | — |
| Omar IshrakDirector | — | — | Nov 9, 2026 | — | — |
| Wanda M. AustinDirector | — | — | May 21, 2026 | — | — |
| Brian DrukerDirector | — | — | May 21, 2026 | — | — |
| Robert EckertDirector | — | — | May 21, 2026 | — | — |
| Greg C. GarlandDirector | — | — | May 21, 2026 | — | — |
| Tyler JacksDirector | — | — | May 21, 2026 | — | — |
| Mary E. KlotmanDirector | — | — | May 21, 2026 | — | — |
| Ellen Jamison KullmanDirector | — | — | May 21, 2026 | — | — |
| Amy E. MilesDirector | — | — | May 21, 2026 | — | — |
| Robert A. BradwayCEO, President | — | — | May 11, 2026 | — | — |
| Peter H. GriffithCFO | — | — | May 11, 2026 | — | — |
| David M. ReeseCTO | — | — | May 11, 2026 | — | — |
| Jonathan P. GrahamEvp & Gen. Counsel & Sec. | — | — | May 11, 2026 | — | — |
| James E. BradnerEvp, Research And Development | — | — | May 11, 2026 | — | — |
Board links: companies that share insiders with AMGN
Directors and executives who filed Form 4s for AMGN and another company in the last 12 months.
- AAPLApple Wanda M. Austin Director here · Director at AAPL · latest filing May 21, 2026
- CVXChevron Wanda M. Austin Director here · Director at CVX · latest filing May 29, 2026
- DELLDell Technologies Ellen Jamison Kullman Director here · Director at DELL · latest filing Sep 28, 2026
- PEPPepsiCo David W. Gibbs Director here · Director at PEP · latest filing Nov 9, 2026
- PSXPhillips 66 Charles M. Holley Director here · Director at PSX · latest filing Nov 9, 2026
- TMOThermo Fisher Scientific Tyler Jacks Director here · Director at TMO · latest filing May 22, 2026
- XOMExxonMobil Greg C. Garland Director here · Director at XOM · latest filing May 21, 2026
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
AMGN stock: common questions
Are Amgen insiders buying AMGN stock?
No. No Amgen insider reported an open-market purchase of AMGN in the past 12 months.
Are Amgen insiders selling AMGN stock?
5 insiders reported sales worth $26.7M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is AMGN's P/E ratio?
AMGN trades at about 28.5 times trailing earnings, compared with a median of 25.0 for the Health Care sector.
What is AMGN's 52-week range?
Over the past year AMGN has traded between $307.56 and $478.48. It last closed at $438.92 on Nov 20, 2026.